$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly CEO on $27 billion in new U.S. manufacturing investments
11:35am, Wednesday, 26'th Feb 2025
Eli Lilly said it will invest at least $27 billion to build four new manufacturing sites in the U.S. as demand for its weight loss and diabetes injections soars and the company develops new drugs.
Eli Lilly CEO on $27 billion investment in U.S. manufacturing expansion
11:06am, Wednesday, 26'th Feb 2025
CNBC's Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S. manufacturing sites expansion, tariffs and domestic jobs.
Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
09:38am, Wednesday, 26'th Feb 2025
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of dr
Novo Nordisk should withstand competition from new Eli Lilly diabetes drug, says Wall Street bank
09:32am, Wednesday, 26'th Feb 2025
JP Morgan is optimistic about Novo Nordisk (NYSE:NVO) despite competition from Eli Lilly's new drug, orforglipron. Its analysts reckon Novo will hold its ground if Lilly's upcoming trial results matc
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
09:30am, Wednesday, 26'th Feb 2025
Eli Lilly said it will invest at least $27 billion to build four new manufacturing sites in the U.S. as demand for its weight loss and diabetes injections soars and the company develops new drugs. The
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
09:30am, Wednesday, 26'th Feb 2025
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America The company's plans represent the largest pha
Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients
01:31pm, Tuesday, 25'th Feb 2025
Eli Lilly (LLY) on Tuesday lowered the price of its weight-loss drug Zepbound for some patients paying out of pocket and introduced two new available vial doses.
Why Eli Lilly Stock Popped Today
12:35pm, Tuesday, 25'th Feb 2025
Eli Lilly (LLY 2.10%) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases.
Eli Lilly introduces new doses of weight loss drug Zepbound at discounted prices
12:06pm, Tuesday, 25'th Feb 2025
Eli Lilly and Co (NYSE:LLY) has announced a reduction in the price of its weight-loss medication Zepbound for patients who pay for the drug out of pocket. The company is now offering higher-dose 5
Eli Lilly: Load Up Before It Leaves You Behind
09:00am, Tuesday, 25'th Feb 2025
Eli Lilly investors have been "quietly" loading up, as the stock outperformed the S&P 500. Lilly has been making gains against Novo Nordisk, and the advance may not be over. Policy risks and pricing c
Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients
07:53am, Tuesday, 25'th Feb 2025
The drug company is calling on insurers and federal programs to include coverage of obesity as a chronic disease.
Eli Lilly Unveils Higher Single-Dose Zepbound Vials for $499 a Month
07:49am, Tuesday, 25'th Feb 2025
Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen
06:48am, Tuesday, 25'th Feb 2025
Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at a $150 discount to the cost of the injector pen versions, as it seeks to sp
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
06:45am, Tuesday, 25'th Feb 2025
Eli Lilly released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for the blockbus
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients
06:45am, Tuesday, 25'th Feb 2025
New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program 2.5 mg and 5 mg vial prices reduced INDIANAPOLIS , Feb. 25, 2025 /PRNewswire/ --
Sign In
Buy LLY